COMPASS Pathways plc (ticker: CMPS) recently announced that its innovative therapy Comp360 psilocybin for treatment-resistant depression has successfully achieved the primary endpoint in the second pivotal Phase 3 clinical trial.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This groundbreaking development marks a solid step forward in validating the safety and efficacy of this therapy, bringing new hope to millions of patients worldwide suffering from treatment-resistant depression.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$78,042.2
+0.95%
Ethereum
ETH
$2,269.27
+1.24%
Tether USDt
USDT
$0.9988
-0.01%
BNB
BNB
$713.32
+1.67%
XRP
XRP
$1.25
+0.54%
USDC
USDC
$0.9997
-0.00%
Solana
SOL
$95.53
+0.16%
TRON
TRX
$0.3102
-2.38%
Hyperliquid
HYPE
$87.69
+0.32%
Zcash
ZEC
$1,248.39
-2.01%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now